Trials / Conditions / NLRC4-MAS
NLRC4-MAS
3 registered clinical trials studyying NLRC4-MAS — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency As Open Label Extension NCT03512314 | AB2 Bio Ltd. | Phase 3 |
| Completed | Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency NCT03113760 | AB2 Bio Ltd. | Phase 3 |
| Recruiting | Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4 NCT02974595 | National Institute of Allergy and Infectious Diseases (NIAID) | — |